Trent joined Peel in 2016 and is responsible for the day-to-day operations of Peel Therapeutics. He is also responsible for the management of contract manufacturing organizations and working with Peel consultants to shepherd drug candidates from discovery stage to clinical trials.

Before coming to Peel, he was a lab manager and clinical research coordinator at the Huntsman Cancer Institute. He has experience coordinating clinical research through all the phases of drug development in indications that include Alzheimer’s, Parkinson’s and Adult and Cancer.

He holds a BS degree from Westmont College and an MBA at the J.L. Kellogg School of Management.

Fun Fact:
Trent has taken up woodworking with a penchant for crafting butcher blocks and coffee tables.